BioCentury
ARTICLE | Company News

Andrulis Pharmaceuticals Corp., University of Verona deal

August 14, 1995 7:00 AM UTC

Andrulis and the University of Verona will study the ability of thalidomide to inhibit the production of cytokines by immune system cells of the brain. The Verona scientists hypothesize that inflammatory cytokines and free radicals may be responsible for the degeneration observed in Alzheimer's disease. ...